Tapewire

OTC · USD

ODYY

Odyssey Health, Inc.

Export transactions ↓
Tapewire entity
8618
SEC CIK
0001626644
Parsed reports
47

Last 12 months

Inside the activity.

0 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
June 28, 2024 Filed Jul 16, 2024 17:10 UTC
FARRELL CHRISTINEChief Financial Officer
GrantStock Option (Right to Buy) · Derivative 500,000 $0.10 Strike: $0.10 $50,000.00
Disclosure

SEC source: 0001683168-24-004905 · ownership.xml · derivative · entry 1

FARRELL CHRISTINE · CIK 0001200160 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 500,000

Underlying: Common Stock · 500,000 shares

Expires 2034-06-27

F1 · shares: The options vest 100,000 immediately; 100,000 vest on July 31, 2024; 100,000 vest on October 31, 2024; 100,000 vest on January 31, 2025; and 100,000 vest on April 30, 2025.

F1 · derivative.underlying_shares: The options vest 100,000 immediately; 100,000 vest on July 31, 2024; 100,000 vest on October 31, 2024; 100,000 vest on January 31, 2025; and 100,000 vest on April 30, 2025.

F1 · balance_after: The options vest 100,000 immediately; 100,000 vest on July 31, 2024; 100,000 vest on October 31, 2024; 100,000 vest on January 31, 2025; and 100,000 vest on April 30, 2025.

Read SEC document
June 28, 2024 Filed Jul 16, 2024 17:10 UTC GrantStock Option (Right to Buy · Derivative 300,000 $0.10 Strike: $0.10 $30,000.00
Disclosure

SEC source: 0001683168-24-004904 · ownership.xml · derivative · entry 1

RICHARDSON RICKY · CIK 0001200164 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 300,000

Underlying: Common Stock · 300,000 shares

Expires 2034-06-27

F1 · shares: The options vest 60,000 immediately; 60,000 vest on July 31, 2024; 60,000 vest on October 31, 2024; 60,000 vest on January 31, 2025; and 60,000 vest on April 30, 2025.

F1 · derivative.underlying_shares: The options vest 60,000 immediately; 60,000 vest on July 31, 2024; 60,000 vest on October 31, 2024; 60,000 vest on January 31, 2025; and 60,000 vest on April 30, 2025.

F1 · balance_after: The options vest 60,000 immediately; 60,000 vest on July 31, 2024; 60,000 vest on October 31, 2024; 60,000 vest on January 31, 2025; and 60,000 vest on April 30, 2025.

Read SEC document
June 28, 2024 Filed Jul 16, 2024 17:10 UTC
REDMOND J MICHAELDirector · President & CEO
GrantStock Option (Right to Buy) · Derivative 500,000 $0.10 Strike: $0.10 $50,000.00
Disclosure

SEC source: 0001683168-24-004902 · ownership.xml · derivative · entry 1

REDMOND J MICHAEL · CIK 0001200166 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 500,000

Underlying: Common Stock · 500,000 shares

Expires 2034-06-27

F1 · shares: The options vest 100,000 immediately; 100,000 vest on July 31, 2024; 100,000 vest on October 31, 2024; 100,000 vest on January 31, 2025; and 100,000 vest on April 30, 2025.

F1 · derivative.underlying_shares: The options vest 100,000 immediately; 100,000 vest on July 31, 2024; 100,000 vest on October 31, 2024; 100,000 vest on January 31, 2025; and 100,000 vest on April 30, 2025.

F1 · balance_after: The options vest 100,000 immediately; 100,000 vest on July 31, 2024; 100,000 vest on October 31, 2024; 100,000 vest on January 31, 2025; and 100,000 vest on April 30, 2025.

Read SEC document
June 28, 2024 Filed Jul 16, 2024 17:10 UTC GrantStock Option (Right to Buy) · Derivative 300,000 $0.10 Strike: $0.10 $30,000.00
Disclosure

SEC source: 0001683168-24-004903 · ownership.xml · derivative · entry 1

Casey Jerome H · CIK 0001794095 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 300,000

Underlying: Common Stock · 300,000 shares

Expires 2034-06-27

F1 · shares: The options vest 60,000 immediately; 60,000 vest on July 31, 2024; 60,000 vest on October 31, 2024; 60,000 vest on January 31, 2025; and 60,000 vest on April 30, 2025.

F1 · derivative.underlying_shares: The options vest 60,000 immediately; 60,000 vest on July 31, 2024; 60,000 vest on October 31, 2024; 60,000 vest on January 31, 2025; and 60,000 vest on April 30, 2025.

F1 · balance_after: The options vest 60,000 immediately; 60,000 vest on July 31, 2024; 60,000 vest on October 31, 2024; 60,000 vest on January 31, 2025; and 60,000 vest on April 30, 2025.

Read SEC document
June 28, 2024 Filed Jul 16, 2024 17:10 UTC
Gironda Gregory WChief Operating Officer
GrantStock Option (Right to Buy · Derivative 250,000 $0.10 Strike: $0.10 $25,000.00
Disclosure

SEC source: 0001683168-24-004901 · ownership.xml · derivative · entry 1

Gironda Gregory W · CIK 0001955096 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 250,000

Underlying: Common Stock · 250,000 shares

Expires 2034-06-27

F1 · shares: The options vest 50,000 immediately; 50,000 vest on July 31, 2024; 50,000 vest on October 31, 2024; 50,000 vest on January 31, 2025; and 50,000 vest on April 30, 2025.

F1 · derivative.underlying_shares: The options vest 50,000 immediately; 50,000 vest on July 31, 2024; 50,000 vest on October 31, 2024; 50,000 vest on January 31, 2025; and 50,000 vest on April 30, 2025.

F1 · balance_after: The options vest 50,000 immediately; 50,000 vest on July 31, 2024; 50,000 vest on October 31, 2024; 50,000 vest on January 31, 2025; and 50,000 vest on April 30, 2025.

Read SEC document
January 16, 2024 Filed Jan 18, 2024 17:10 UTC
Gironda Gregory WChief Operating Officer
GrantStock Option (Right to Buy) · Derivative 37,500 $0.09 Strike: $0.09 $3,187.50
Disclosure

SEC source: 0001683168-24-000341 · ownership.xml · derivative · entry 1

Gironda Gregory W · CIK 0001955096 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,500

Underlying: Common Stock · 37,500 shares

Expires 2034-01-15

F1 · shares: The non-qualified stock options are granted outside the Amended and Restated 2021 Omnibus Stock Incentive Plan, vesting immediately and the exercise price is the closing price on the date of the grant, January 16, 2024.

F1 · derivative.underlying_shares: The non-qualified stock options are granted outside the Amended and Restated 2021 Omnibus Stock Incentive Plan, vesting immediately and the exercise price is the closing price on the date of the grant, January 16, 2024.

F1 · balance_after: The non-qualified stock options are granted outside the Amended and Restated 2021 Omnibus Stock Incentive Plan, vesting immediately and the exercise price is the closing price on the date of the grant, January 16, 2024.

Read SEC document
January 16, 2024 Filed Jan 18, 2024 17:10 UTC
Emerson Erik C.Chief Commerical Officer
GrantStock Option (Right to Buy) · Derivative 37,500 $0.09 Strike: $0.09 $3,187.50
Disclosure

SEC source: 0001683168-24-000340 · ownership.xml · derivative · entry 1

Emerson Erik C. · CIK 0001710496 · Chief Commerical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,500

Underlying: Common Stock · 37,500 shares

Expires 2034-01-15

F1 · shares: The non-qualified stock options are granted outside the Amended and Restated 2021 Omnibus Stock Incentive Plan, vesting immediately and the exercise price is the closing price on the date of the grant, January 16, 2024.

F1 · derivative.underlying_shares: The non-qualified stock options are granted outside the Amended and Restated 2021 Omnibus Stock Incentive Plan, vesting immediately and the exercise price is the closing price on the date of the grant, January 16, 2024.

F1 · balance_after: The non-qualified stock options are granted outside the Amended and Restated 2021 Omnibus Stock Incentive Plan, vesting immediately and the exercise price is the closing price on the date of the grant, January 16, 2024.

Read SEC document
January 10, 2024 Filed Jan 16, 2024 17:10 UTC
GANDOLFO JOHN PFormer Director
Disposition to issuerRestricted Stock Unit (Right to Buy) · Derivative 1,500,000 $0.09 Strike: $0.09 $135,000.00
Disclosure

SEC source: 0001683168-24-000304 · ownership.xml · derivative · entry 2

GANDOLFO JOHN P · CIK 0001200155 · Former Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: ODYY Common Stock · 1,500,000 shares

Expires 2024-01-17

Read SEC document
January 10, 2024 Filed Jan 16, 2024 17:10 UTC
GANDOLFO JOHN PFormer Director
GrantODYY - Common Stock 1,500,000 $0.09 $135,000.00
Disclosure

SEC source: 0001683168-24-000304 · ownership.xml · nonDerivative · entry 1

GANDOLFO JOHN P · CIK 0001200155 · Former Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,738,792

Read SEC document
December 29, 2023 Filed Jan 2, 2024 17:10 UTC
FARRELL CHRISTINEChief Financial Officer
GrantStock Option (Right to Buy) · Derivative 500,000 $0.10 Strike: $0.10 $50,000.00
Disclosure

SEC source: 0001683168-24-000025 · ownership.xml · derivative · entry 1

FARRELL CHRISTINE · CIK 0001200160 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 500,000

Underlying: Common Stock · 500,000 shares

Expires 2033-12-28

F1 · shares: The options vest immediately and the exercise price is the closing price on the date of the grant, December 29, 2023

F1 · derivative.underlying_shares: The options vest immediately and the exercise price is the closing price on the date of the grant, December 29, 2023

F1 · balance_after: The options vest immediately and the exercise price is the closing price on the date of the grant, December 29, 2023

Read SEC document
December 29, 2023 Filed Jan 2, 2024 17:10 UTC
REDMOND J MICHAELDirector · President & CEO
GrantStock Option (Right to Buy) · Derivative 500,000 $0.10 Strike: $0.10 $50,000.00
Disclosure

SEC source: 0001683168-24-000024 · ownership.xml · derivative · entry 1

REDMOND J MICHAEL · CIK 0001200166 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 500,000

Underlying: Common Stock · 500,000 shares

Expires 2033-12-28

F1 · shares: The options vest immediately and the exercise price is the closing price on the date of the grant, December 29, 2023

F1 · derivative.underlying_shares: The options vest immediately and the exercise price is the closing price on the date of the grant, December 29, 2023

F1 · balance_after: The options vest immediately and the exercise price is the closing price on the date of the grant, December 29, 2023

Read SEC document
December 29, 2023 Filed Jan 2, 2024 17:10 UTC GrantStock Option (Right to Buy) · Derivative 250,000 $0.10 Strike: $0.10 $25,000.00
Disclosure

SEC source: 0001683168-24-000021 · ownership.xml · derivative · entry 1

RICHARDSON RICKY · CIK 0001200164 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 250,000

Underlying: Common Stock · 250,000 shares

Expires 2033-12-28

F1 · shares: The options vest immediately and the exercise price is the closing price on the date of the grant, December 29, 2023

F1 · derivative.underlying_shares: The options vest immediately and the exercise price is the closing price on the date of the grant, December 29, 2023

F1 · balance_after: The options vest immediately and the exercise price is the closing price on the date of the grant, December 29, 2023

Read SEC document
December 29, 2023 Filed Jan 2, 2024 17:10 UTC
Emerson Erik C.Chief Commerical Officer
GrantStock Option (Right to Buy) · Derivative 200,000 $0.10 Strike: $0.10 $20,000.00
Disclosure

SEC source: 0001683168-24-000026 · ownership.xml · derivative · entry 1

Emerson Erik C. · CIK 0001710496 · Chief Commerical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 200,000

Underlying: Common Stock · 200,000 shares

Expires 2033-12-28

F1 · shares: The options vest immediately and the exercise price is the closing price on the date of the grant, December 29, 2023

F1 · derivative.underlying_shares: The options vest immediately and the exercise price is the closing price on the date of the grant, December 29, 2023

F1 · balance_after: The options vest immediately and the exercise price is the closing price on the date of the grant, December 29, 2023

Read SEC document
December 29, 2023 Filed Jan 2, 2024 17:10 UTC
Gironda Gregory WChief Operating Officer
GrantStock Option (Right to Buy) · Derivative 200,000 $0.10 Strike: $0.10 $20,000.00
Disclosure

SEC source: 0001683168-24-000023 · ownership.xml · derivative · entry 1

Gironda Gregory W · CIK 0001955096 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 200,000

Underlying: Common Stock · 200,000 shares

Expires 2033-12-28

F1 · shares: The options vest immediately and the exercise price is the closing price on the date of the grant, December 29, 2023

F1 · derivative.underlying_shares: The options vest immediately and the exercise price is the closing price on the date of the grant, December 29, 2023

F1 · balance_after: The options vest immediately and the exercise price is the closing price on the date of the grant, December 29, 2023

Read SEC document
December 29, 2023 Filed Jan 2, 2024 17:10 UTC GrantStock Option (Right to Buy) · Derivative 250,000 $0.10 Strike: $0.10 $25,000.00
Disclosure

SEC source: 0001683168-24-000022 · ownership.xml · derivative · entry 1

Casey Jerome H · CIK 0001794095 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 250,000

Underlying: Common Stock · 250,000 shares

Expires 2033-12-28

F1 · shares: The options vest immediately and the exercise price is the closing price on the date of the grant, December 29, 2023

F1 · derivative.underlying_shares: The options vest immediately and the exercise price is the closing price on the date of the grant, December 29, 2023

F1 · balance_after: The options vest immediately and the exercise price is the closing price on the date of the grant, December 29, 2023

Read SEC document
January 12, 2023 Filed Jan 13, 2023 17:16 UTC GrantRestricted Stock Unit (Right to Buy) · Derivative 500,000 $0.30 Strike: $0.30 $150,000.00
Disclosure

SEC source: 0001683168-23-000192 · ownership.xml · derivative · entry 1

GANDOLFO JOHN P · CIK 0001200155 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,500,000

Underlying: ODYY - Common Stock · 500,000 shares

Expires not disclosed

F1 · derivative.expiration_date: No expiration date

Read SEC document
January 12, 2023 Filed Jan 13, 2023 17:15 UTC GrantRestricted Stock Unit (Right to Buy) · Derivative 400,000 $0.30 Strike: $0.30 $120,000.00
Disclosure

SEC source: 0001683168-23-000191 · ownership.xml · derivative · entry 2

FARRELL CHRISTINE · CIK 0001200160 · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,700,000

Underlying: ODYY - Common Stock · 400,000 shares

Expires not disclosed

F1 · derivative.expiration_date: No expiration date

Read SEC document
January 12, 2023 Filed Jan 13, 2023 17:15 UTC GrantRestricted Stock Unit (Right to Buy) · Derivative 100,000 $0.30 Strike: $0.30 $30,000.00
Disclosure

SEC source: 0001683168-23-000191 · ownership.xml · derivative · entry 1

FARRELL CHRISTINE · CIK 0001200160 · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,300,000

Underlying: ODYY - Common Stock · 100,000 shares

Expires not disclosed

F1 · derivative.expiration_date: No expiration date

Read SEC document
January 12, 2023 Filed Jan 13, 2023 17:16 UTC GrantRestricted Stock Unit (Right to Buy) · Derivative 500,000 $0.30 Strike: $0.30 $150,000.00
Disclosure

SEC source: 0001683168-23-000194 · ownership.xml · derivative · entry 1

RICHARDSON RICKY · CIK 0001200164 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,000,000

Underlying: ODYY - Common Stock · 500,000 shares

Expires not disclosed

F1 · derivative.expiration_date: No expiration date

Read SEC document
January 12, 2023 Filed Jan 13, 2023 17:16 UTC
REDMOND J MICHAELDirector · President & CEO
GrantRestricted Stock Unit (Right to Buy) · Derivative 400,000 $0.30 Strike: $0.30 $120,000.00
Disclosure

SEC source: 0001683168-23-000193 · ownership.xml · derivative · entry 2

REDMOND J MICHAEL · CIK 0001200166 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,500,000

Underlying: ODYY - Common Stock · 400,000 shares

Expires not disclosed

F1 · derivative.expiration_date: No expiration date

Read SEC document
January 12, 2023 Filed Jan 13, 2023 17:16 UTC
REDMOND J MICHAELDirector · President & CEO
GrantRestricted Stock Unit (Right to Buy) · Derivative 100,000 $0.30 Strike: $0.30 $30,000.00
Disclosure

SEC source: 0001683168-23-000193 · ownership.xml · derivative · entry 1

REDMOND J MICHAEL · CIK 0001200166 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,100,000

Underlying: ODYY - Common Stock · 100,000 shares

Expires not disclosed

F1 · derivative.expiration_date: No expiration date

Read SEC document
January 12, 2023 Filed Jan 13, 2023 17:15 UTC GrantRestricted Stock Unit (Right to Buy) · Derivative 500,000 $0.30 Strike: $0.30 $150,000.00
Disclosure

SEC source: 0001683168-23-000190 · ownership.xml · derivative · entry 1

Casey Jerome H · CIK 0001794095 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,500,000

Underlying: ODYY - Common Stock · 500,000 shares

Expires not disclosed

F1 · derivative.expiration_date: No expiration date

Read SEC document
November 01, 2022 Filed Nov 23, 2022 16:04 UTC
Gironda Gregory WChief Operating Officer
GrantStock Option - Right to buy · Derivative 475,000 $0.25 Strike: $0.25 $118,750.00
Disclosure

SEC source: 0001683168-22-008024 · ownership.xml · derivative · entry 2

Gironda Gregory W · CIK 0001955096 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 475,000 shares

Expires 2032-10-31

F1 · date: Vesting is as follows: 125,000 vest upon signing of this agreement; 300,000 vest upon a financing by the Company in the amount of $5,000,000 or more; 175,000 vest upon the listing of the Company on a national exchange such as Nasdaq or the NYSE.

F1 · deemedExecutionDate: Vesting is as follows: 125,000 vest upon signing of this agreement; 300,000 vest upon a financing by the Company in the amount of $5,000,000 or more; 175,000 vest upon the listing of the Company on a national exchange such as Nasdaq or the NYSE.

F1 · derivative.exercise_date: Vesting is as follows: 125,000 vest upon signing of this agreement; 300,000 vest upon a financing by the Company in the amount of $5,000,000 or more; 175,000 vest upon the listing of the Company on a national exchange such as Nasdaq or the NYSE.

F1 · balance_after: Vesting is as follows: 125,000 vest upon signing of this agreement; 300,000 vest upon a financing by the Company in the amount of $5,000,000 or more; 175,000 vest upon the listing of the Company on a national exchange such as Nasdaq or the NYSE.

Read SEC document
November 01, 2022 Filed Nov 23, 2022 16:04 UTC
Gironda Gregory WChief Operating Officer
GrantStock Option - Right to buy · Derivative 125,000 $0.25 Strike: $0.25 $31,250.00
Disclosure

SEC source: 0001683168-22-008024 · ownership.xml · derivative · entry 1

Gironda Gregory W · CIK 0001955096 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 125,000

Underlying: Common Stock · 125,000 shares

Expires 2032-10-31

F1 · date: Vesting is as follows: 125,000 vest upon signing of this agreement; 300,000 vest upon a financing by the Company in the amount of $5,000,000 or more; 175,000 vest upon the listing of the Company on a national exchange such as Nasdaq or the NYSE.

F1 · derivative.exercise_date: Vesting is as follows: 125,000 vest upon signing of this agreement; 300,000 vest upon a financing by the Company in the amount of $5,000,000 or more; 175,000 vest upon the listing of the Company on a national exchange such as Nasdaq or the NYSE.

Read SEC document
November 01, 2022 Filed Nov 23, 2022 16:02 UTC
Emerson Erik C.Chief Commercial Officer
GrantStock Option - Right to buy · Derivative 475,000 $0.25 Strike: $0.25 $118,750.00
Disclosure

SEC source: 0001683168-22-008022 · ownership.xml · derivative · entry 2

Emerson Erik C. · CIK 0001710496 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 475,000 shares

Expires 2032-10-31

F1 · date: Vesting is as follows: 125,000 vest upon signing of this agreement; 300,000 vest upon a financing by the Company in the amount of $5,000,000 or more; 175,000 vest upon the listing of the Company on a national exchange such as Nasdaq or the NYSE.

F1 · deemedExecutionDate: Vesting is as follows: 125,000 vest upon signing of this agreement; 300,000 vest upon a financing by the Company in the amount of $5,000,000 or more; 175,000 vest upon the listing of the Company on a national exchange such as Nasdaq or the NYSE.

F1 · derivative.exercise_date: Vesting is as follows: 125,000 vest upon signing of this agreement; 300,000 vest upon a financing by the Company in the amount of $5,000,000 or more; 175,000 vest upon the listing of the Company on a national exchange such as Nasdaq or the NYSE.

F1 · balance_after: Vesting is as follows: 125,000 vest upon signing of this agreement; 300,000 vest upon a financing by the Company in the amount of $5,000,000 or more; 175,000 vest upon the listing of the Company on a national exchange such as Nasdaq or the NYSE.

Read SEC document
November 01, 2022 Filed Nov 23, 2022 16:02 UTC
Emerson Erik C.Chief Commercial Officer
GrantStock Option - Right to buy · Derivative 125,000 $0.25 Strike: $0.25 $31,250.00
Disclosure

SEC source: 0001683168-22-008022 · ownership.xml · derivative · entry 1

Emerson Erik C. · CIK 0001710496 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 125,000

Underlying: Common Stock · 125,000 shares

Expires 2032-10-31

F1 · date: Vesting is as follows: 125,000 vest upon signing of this agreement; 300,000 vest upon a financing by the Company in the amount of $5,000,000 or more; 175,000 vest upon the listing of the Company on a national exchange such as Nasdaq or the NYSE.

F1 · balance_after: Vesting is as follows: 125,000 vest upon signing of this agreement; 300,000 vest upon a financing by the Company in the amount of $5,000,000 or more; 175,000 vest upon the listing of the Company on a national exchange such as Nasdaq or the NYSE.

Read SEC document
October 14, 2022 Filed Oct 19, 2022 21:21 UTC
FARRELL CHRISTINEChief Financial Officer
GrantStock Option (Right to Buy) · Derivative 500,000 $0.32 Strike: $0.32 $159,000.00
Disclosure

SEC source: 0001683168-22-006967 · ownership.xml · derivative · entry 1

FARRELL CHRISTINE · CIK 0001200160 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,100,000

Underlying: Common Stock · 500,000 shares

Expires 2032-10-13

F1 · derivative.exercise_date: 500,000 vesting upon a listing on a higher exchange (OTCQB, Nasdaq or NYSE)

Read SEC document
October 14, 2022 Filed Oct 19, 2022 21:27 UTC GrantStock Option (Right to Buy) · Derivative 1,000,000 $0.32 Strike: $0.32 $318,000.00
Disclosure

SEC source: 0001683168-22-006969 · ownership.xml · derivative · entry 1

VANLANDINGHAM JACOB PH.D · CIK 0001794273 · Related Party

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,100,000

Underlying: Common Stock · 1,000,000 shares

Expires 2032-10-13

F1 · derivative.exercise_date: Vesting Schedule 250,000 upon signing; 250,000 upon an IND being approved by the FDA for Phase 2; 250,000 upon a listing on a national exchange (Nasdaq, NYSE); and 250,000 one year from Effective Date.

Read SEC document
September 02, 2022 Filed Sep 15, 2022 16:16 UTC
REDMOND J MICHAELDirector · President & CEO
GiftCommon Stock 1,500,000 $0.16 $244,950.00
Disclosure

SEC source: 0001683168-22-006423 · ownership.xml · nonDerivative · entry 1

REDMOND J MICHAEL · CIK 0001200166 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,500,000

F1 · shares: Shares gifted are 500,000 shares of common stock gifted to Sean M Redmond; 500,000 shares of common stock gifted to Conor J. Redmond; 500,000 shares of common stock gifted to Devin P. Redmond.

Read SEC document
June 10, 2022 Filed Jun 14, 2022 16:10 UTC
VANLANDINGHAM JACOB PH.DVP of Drug Development
GrantODYY common stock $0.001 par value 1,000,000 $0.23 $230,000.00
Disclosure

SEC source: 0001683168-22-004341 · ownership.xml · nonDerivative · entry 1

VANLANDINGHAM JACOB PH.D · CIK 0001794273 · VP of Drug Development

10b5-1 filing: Not disclosed

Ownership: Indirect · By Prevacus, Inc.

Disclosed balance after: 9,660,000

Read SEC document
May 19, 2022 Filed Jun 8, 2022 17:17 UTC GrantStock Option (Right to Buy) · Derivative 250,000 $0.30 Strike: $0.30 $75,000.00
Disclosure

SEC source: 0001683168-22-004241 · ownership.xml · derivative · entry 2

GANDOLFO JOHN P · CIK 0001200155 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,500,000

Underlying: Common Stock · 250,000 shares

Expires 2032-05-18

Read SEC document
May 19, 2022 Filed Jun 8, 2022 17:17 UTC GrantStock Option (Right to Buy) · Derivative 250,000 $0.30 Strike: $0.30 $75,000.00
Disclosure

SEC source: 0001683168-22-004241 · ownership.xml · derivative · entry 1

GANDOLFO JOHN P · CIK 0001200155 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,250,000

Underlying: Common Stock · 250,000 shares

Expires 2032-05-19

Read SEC document
May 19, 2022 Filed Jun 8, 2022 17:18 UTC GrantStock Option (Right to Buy) · Derivative 250,000 $0.30 Strike: $0.30 $75,000.00
Disclosure

SEC source: 0001683168-22-004243 · ownership.xml · derivative · entry 2

RICHARDSON RICKY · CIK 0001200164 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,000,000

Underlying: Common Stock · 250,000 shares

Expires 2032-05-19

Read SEC document
May 19, 2022 Filed Jun 8, 2022 17:18 UTC GrantStock Option (Right to Buy) · Derivative 250,000 $0.30 Strike: $0.30 $75,000.00
Disclosure

SEC source: 0001683168-22-004243 · ownership.xml · derivative · entry 1

RICHARDSON RICKY · CIK 0001200164 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 750,000

Underlying: Common Stock · 250,000 shares

Expires 2032-05-19

Read SEC document
May 19, 2022 Filed Jun 8, 2022 17:16 UTC
FARRELL CHRISTINEChief Financial Officer
GrantStock Option (Right to Buy) · Derivative 300,000 $0.30 Strike: $0.30 $90,000.00
Disclosure

SEC source: 0001683168-22-004240 · ownership.xml · derivative · entry 2

FARRELL CHRISTINE · CIK 0001200160 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,600,000

Underlying: Common Stock · 300,000 shares

Expires 2032-05-18

Read SEC document
May 19, 2022 Filed Jun 8, 2022 17:16 UTC
FARRELL CHRISTINEChief Financial Officer
GrantStock Option (Right to Buy) · Derivative 300,000 $0.30 Strike: $0.30 $90,000.00
Disclosure

SEC source: 0001683168-22-004240 · ownership.xml · derivative · entry 1

FARRELL CHRISTINE · CIK 0001200160 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,300,000

Underlying: Common Stock · 300,000 shares

Expires 2032-05-18

Read SEC document
May 19, 2022 Filed Jun 8, 2022 17:17 UTC
REDMOND J MICHAELDirector · President/CEO
GrantStock Option (Right to Buy) · Derivative 375,000 $0.30 Strike: $0.30 $112,500.00
Disclosure

SEC source: 0001683168-22-004242 · ownership.xml · derivative · entry 2

REDMOND J MICHAEL · CIK 0001200166 · Director · President/CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,750,000

Underlying: Common Stock · 375,000 shares

Expires 2032-05-18

Read SEC document
May 19, 2022 Filed Jun 8, 2022 17:17 UTC
REDMOND J MICHAELDirector · President/CEO
GrantStock Option (Right to Buy) · Derivative 375,000 $0.30 Strike: $0.30 $112,500.00
Disclosure

SEC source: 0001683168-22-004242 · ownership.xml · derivative · entry 1

REDMOND J MICHAEL · CIK 0001200166 · Director · President/CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,375,000

Underlying: Common Stock · 375,000 shares

Expires 2032-05-18

Read SEC document
May 19, 2022 Filed Jun 8, 2022 17:18 UTC
VANLANDINGHAM JACOB PH.DVP of Drug Development
GrantStock Option (Right to Buy) · Derivative 100,000 $0.30 Strike: $0.30 $30,000.00
Disclosure

SEC source: 0001683168-22-004244 · ownership.xml · derivative · entry 1

VANLANDINGHAM JACOB PH.D · CIK 0001794273 · VP of Drug Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,100,000

Underlying: Common Stock · 100,000 shares

Expires 2032-05-19

F1 · derivative.exercise_date: Vesting Schedule: 50% vest on first dosed subject of Phase 2 Trial; 50% on last dosed subject of Phase 2 Trial.

Read SEC document
May 19, 2022 Filed Jun 8, 2022 17:16 UTC GrantStock Option (Right to Buy) · Derivative 250,000 $0.30 Strike: $0.30 $75,000.00
Disclosure

SEC source: 0001683168-22-004239 · ownership.xml · derivative · entry 2

Conroy Jeffrey X · CIK 0001794086 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,500,000

Underlying: Common Stock · 250,000 shares

Expires 2032-05-19

Read SEC document
May 19, 2022 Filed Jun 8, 2022 17:16 UTC GrantStock Option (Right to Buy) · Derivative 250,000 $0.30 Strike: $0.30 $75,000.00
Disclosure

SEC source: 0001683168-22-004239 · ownership.xml · derivative · entry 1

Conroy Jeffrey X · CIK 0001794086 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,250,000

Underlying: Common Stock · 250,000 shares

Expires 2032-05-18

Read SEC document
May 19, 2022 Filed Jun 8, 2022 17:16 UTC GrantStock Option (Right to Buy) · Derivative 250,000 $0.30 Strike: $0.30 $75,000.00
Disclosure

SEC source: 0001683168-22-004238 · ownership.xml · derivative · entry 2

Casey Jerome H · CIK 0001794095 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,500,000

Underlying: Common Stock · 250,000 shares

Expires 2032-05-18

Read SEC document
May 19, 2022 Filed Jun 8, 2022 17:16 UTC GrantStock Option (Right to Buy) · Derivative 250,000 $0.30 Strike: $0.30 $75,000.00
Disclosure

SEC source: 0001683168-22-004238 · ownership.xml · derivative · entry 1

Casey Jerome H · CIK 0001794095 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,250,000

Underlying: Common Stock · 250,000 shares

Expires 2032-05-18

Read SEC document
September 14, 2021 Filed Sep 16, 2021 17:35 UTC GrantRestricted Stock Unit (Right to Buy) · Derivative 500,000 $0.45 Strike: $0.45 $225,000.00
Disclosure

SEC source: 0001683168-21-004319 · ownership.xml · derivative · entry 1

GANDOLFO JOHN P · CIK 0001200155 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,000,000

Underlying: Common Stock · 500,000 shares

Expires not disclosed

F1 · derivative.exercise_date: The vesting of the RSU (Units) is as follows: 500,000 RSU vest equally over 12 months, subject to the Grantee's continuous service through the applicable vesting date. If not forfeited, vesting of the Units will be accelerated and will vest in full immediately upon the closing of a Corporate Transaction, provided that Grantee provides Continuous Service to the Company through the date such Corporate Transaction is closed. Vested Units will be settled by delivering to Grantee a number of shares equal to the number of vested Units on the earlier of the date on which the Grantee's Continuous Service ends, or the closing of a Corporate Transaction.

F2 · derivative.expiration_date: No expiration.

Read SEC document
September 14, 2021 Filed Sep 16, 2021 17:35 UTC GrantRestricted Stock Unit (Right to Buy) · Derivative 500,000 $0.45 Strike: $0.45 $225,000.00
Disclosure

SEC source: 0001683168-21-004318 · ownership.xml · derivative · entry 1

Conroy Jeffrey X · CIK 0001794086 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,000,000

Underlying: Common Stock · 500,000 shares

Expires not disclosed

F1 · derivative.exercise_date: The vesting of the RSU (Units) is as follows: 500,000 RSU vest equally over 12 months, subject to the Grantee's continuous service through the applicable vesting date. If not forfeited, vesting of the Units will be accelerated and will vest in full immediately upon the closing of a Corporate Transaction, provided that Grantee provides Continuous Service to the Company through the date such Corporate Transaction is closed. Vested Units will be settled by delivering to Grantee a number of shares equal to the number of vested Units on the earlier of the date on which the Grantee's Continuous Service ends, or the closing of a Corporate Transaction.

F2 · derivative.expiration_date: No expiration.

Read SEC document
September 14, 2021 Filed Sep 16, 2021 17:34 UTC GrantRestricted Stock Unit (Right to Buy) · Derivative 500,000 $0.45 Strike: $0.45 $225,000.00
Disclosure

SEC source: 0001683168-21-004317 · ownership.xml · derivative · entry 1

Casey Jerome H · CIK 0001794095 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,000,000

Underlying: Common Stock · 500,000 shares

Expires not disclosed

F1 · derivative.exercise_date: The vesting of the RSU (Units) is as follows: 500,000 RSU vest equally over 12 months, subject to the Grantee's continuous service through the applicable vesting date. If not forfeited, vesting of the Units will be accelerated and will vest in full immediately upon the closing of a Corporate Transaction, provided that Grantee provides Continuous Service to the Company through the date such Corporate Transaction is closed. Vested Units will be settled by delivering to Grantee a number of shares equal to the number of vested Units on the earlier of the date on which the Grantee's Continuous Service ends, or the closing of a Corporate Transaction.

F2 · derivative.expiration_date: No expiration.

Read SEC document
March 01, 2021 Filed Apr 9, 2021 17:01 UTC GrantStock Option (Right to Buy) · Derivative 1,000,000 $1.18 Strike: $1.18 $1,180,000.00
Disclosure

SEC source: 0001683168-21-001306 · ownership.xml · derivative · entry 1

VANLANDINGHAM JACOB PH.D · CIK 0001794273 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,000,000

Underlying: ODYY - Common Stock · 1,000,000 shares

Expires 2024-03-01

F1 · derivative.exercise_date: Vesting schedule: 250,000 shares vest on signing of closing documents; 250,000 shares vest on Phase 1a first dosing of human; 250,000 shares vest on Phase 1b first dosing of human; and 250,000 shares vest upon Company being accepted on NASDAQ.

Read SEC document
January 01, 2021 Filed Mar 1, 2021 19:46 UTC
FARRELL CHRISTINEChief Financial Officer
GrantRestricted Stock Unit (Right to Buy) · Derivative 1,000,000 $0.18 Strike: $0.18 $180,000.00
Disclosure

SEC source: 0001683168-21-000746 · ownership.xml · derivative · entry 1

FARRELL CHRISTINE · CIK 0001200160 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,000,000

Underlying: ODYY - Common Stock · 1,000,000 shares

Expires not disclosed

F1 · derivative.exercise_date: The vesting of the RSU (Units) is as follows: 1,000,000 RSU vesting equally over 36 months, subject to the Grantee's continuous service through the applicable vesting date. If not forfeited, vesting of the Units will be accelerated and will vest in full immediately upon the closing of a Corporate Transaction, provided that Grantee provides Continuous Service to the Company through the date such Corporate Transaction is closed. Vested Units will be settled by delivering to Grantee a number of shares equal to the number of vested Units on the earlier of the date on which the Grantee's Continuous Service ends, or the closing of a Corporate Transaction.

F2 · derivative.expiration_date: No expiration.

Read SEC document
January 01, 2021 Filed Mar 1, 2021 19:46 UTC
REDMOND J MICHAELDirector · President/CEO
GrantRestricted Stock Unit (Right to Buy · Derivative 3,000,000 $0.18 Strike: $0.18 $540,000.00
Disclosure

SEC source: 0001683168-21-000747 · ownership.xml · derivative · entry 1

REDMOND J MICHAEL · CIK 0001200166 · Director · President/CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,000,000

Underlying: ODYY - Common Stock · 3,000,000 shares

Expires not disclosed

F1 · derivative.exercise_date: The vesting of the RSU (Units) is as follows: 3,000,000 RSU vesting equally over 36 months, subject to the Grantee's continuous service through the applicable vesting date. If not forfeited, vesting of the Units will be accelerated and will vest in full immediately upon the closing of a Corporate Transaction, provided that Grantee provides Continuous Service to the Company through the date such Corporate Transaction is closed. Vested Units will be settled by delivering to Grantee a number of shares equal to the number of vested Units on the earlier of the date on which the Grantee's Continuous Service ends, or the closing of a Corporate Transaction.

F2 · derivative.expiration_date: No expiration.

Read SEC document
September 16, 2020 Filed Mar 1, 2021 19:46 UTC
REDMOND J MICHAELDirector · President/CEO
OtherODYY - Common Stock Option · Derivative 15,000,000 $0.25 Strike: $0.25 $3,750,000.00
Disclosure

SEC source: 0001683168-21-000747 · ownership.xml · derivative · entry 2

REDMOND J MICHAEL · CIK 0001200166 · Director · President/CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,000,000

Underlying: ODYY - Common Stock · 15,000,000 shares

Expires not disclosed

F3 · kind: Options not earned or vested and cancelled September 16, 2020

F2 · derivative.exercise_date: No expiration.

F2 · derivative.expiration_date: No expiration.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.